Ad is loading...
BRUEX
Price
$17.57
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
VVIAX
Price
$69.72
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
Ad is loading...

BRUEX vs VVIAX

Header iconBRUEX vs VVIAX Comparison
Open Charts BRUEX vs VVIAXBanner chart's image
MFS Blended Research Value Equity B
Price$17.57
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index Adm
Price$69.72
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
BRUEX vs VVIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BRUEX vs. VVIAX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRUEX is a StrongBuy and VVIAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 184B vs. BRUEX (294M). VVIAX pays higher dividends than BRUEX: VVIAX (2.36) vs BRUEX (0.00). BRUEX was incepted earlier than VVIAX: BRUEX (9 years) vs VVIAX (24 years). BRUEX is a more actively managed with annual turnover of: 51.00 vs. VVIAX (10.00). BRUEX has a lower initial minimum investment than VVIAX: BRUEX (1000) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 26.09 vs. BRUEX (23.65). VVIAX return over 5 years is better than : 53.09 vs. BRUEX (33.56).
BRUEXVVIAXBRUEX / VVIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years24 years-
Gain YTD17.68319.67290%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets294M184B0%
Annual Yield % from dividends0.002.36-
Returns for 1 year23.6526.0991%
Returns for 3 years5.4124.7722%
Returns for 5 years33.5653.0963%
Returns for 10 yearsN/A112.26-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DOLE15.260.19
+1.26%
Dole plc
NCNO40.450.37
+0.92%
nCino
SGHT3.760.03
+0.80%
Sight Sciences
VICI32.370.25
+0.78%
VICI Properties
SABS3.070.01
+0.33%
SAB Biotherapeutics